News
Down 24.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Array Technologies (ARRY)
Array Technologies, Inc. (ARRY) has been on a downward spiral lately with significant selling pressure. After declining 24.3% over the past four weeks, the stock looks well positioned for a trend
Down 23.3% in 4 Weeks, Here's Why Torrid Holdings (CURV) Looks Ripe for a Turnaround
A downtrend has been apparent in Torrid Holdings (CURV) lately with too much selling pressure. The stock has declined 23.3% over the past four weeks. However, given the fact that it is now in
Estee Lauder (EL) Crossed Above the 20-Day Moving Average: What That Means for Investors
Estee Lauder (EL) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, EL crossed above the 20-day moving average, suggesting a
Brokers Suggest Investing in Leidos (LDOS): Read This Before Placing a Bet
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
Brokers Suggest Investing in Kroger (KR): Read This Before Placing a Bet
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
Is Diversified Energy Company PLC (DEC) a Buy as Wall Street Analysts Look Optimistic?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
Should You Invest in Tenet (THC) Based on Bullish Wall Street Views?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
Madison Square Garden (MSGS) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
For the quarter ended June 2025, Madison Square Garden (MSGS) reported revenue of $203.96 million, down 10.3% over the same period last year. EPS came in at -$0.07, compared to $1.06 in the year-ago
Marex Group PLC (MRX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Marex Group PLC (MRX) reported $500.1 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 18.5%. EPS of $1.02 for the same period compares to $0.90 a year
Brokers Suggest Investing in Cardinal (CAH): Read This Before Placing a Bet
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
Kamada (KMDA) Reports Q2 Earnings: What Key Metrics Have to Say
For the quarter ended June 2025, Kamada (KMDA) reported revenue of $44.75 million, up 5.4% over the same period last year. EPS came in at $0.13, compared to $0.08 in the year-ago quarter.
The
Should You Invest in On Holding (ONON) Based on Bullish Wall Street Views?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
Is Interactive Brokers (IBKR) a Buy as Wall Street Analysts Look Optimistic?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
MSG Entertainment (MSGE) Reports Q4 Earnings: What Key Metrics Have to Say
Madison Square Garden Entertainment (MSGE) reported $154.14 million in revenue for the quarter ended June 2025, representing a year-over-year decline of 17.2%. EPS of -$0.50 for the same period
New to Investing? This 1 Computer and Technology Stock Could Be the Perfect Starting Point
Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.
The Zacks Premium
Is Kyndryl Holdings, Inc. (KD) a Buy as Wall Street Analysts Look Optimistic?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts
Should You Invest in UnitedHealth (UNH) Based on Bullish Wall Street Views?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
Here's What Key Metrics Tell Us About European Wax Center (EWCZ) Q2 Earnings
European Wax Center, Inc. (EWCZ) reported $55.91 million in revenue for the quarter ended June 2025, representing a year-over-year decline of 6.6%. EPS of $0.27 for the same period compares to $0.15
Compared to Estimates, Globale Online (GLBE) Q2 Earnings: A Look at Key Metrics
For the quarter ended June 2025, Global-e Online Ltd. (GLBE) reported revenue of $214.88 million, up 27.9% over the same period last year. EPS came in at $0.06, compared to -$0.13 in the year-ago
Is It Worth Investing in Celestica (CLS) Based on Wall Street's Bullish Views?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
Here's What Key Metrics Tell Us About HudBay Minerals (HBM) Q2 Earnings
For the quarter ended June 2025, HudBay Minerals (HBM) reported revenue of $536.4 million, up 26.1% over the same period last year. EPS came in at $0.19, compared to $0 in the year-ago quarter.
The
Ginkgo Bioworks Holdings, Inc. (DNA) Recently Broke Out Above the 50-Day Moving Average
After reaching an important support level, Ginkgo Bioworks Holdings, Inc. (DNA) could be a good stock pick from a technical perspective. DNA surpassed resistance at the 50-day moving average
Brinker International (EAT) Reports Q4 Earnings: What Key Metrics Have to Say
Brinker International (EAT) reported $1.46 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 21%. EPS of $2.49 for the same period compares to $1.61 a
Buy These 3 Stocks With Upgraded Broker Ratings for Solid Returns
Stock markets have been experiencing significant volatility of late. This is largely because of lingering tariff-related headwinds. These concerns include expectations of economic slowdown and
Ovid Therapeutics (OVID) Reports Q2 Loss, Beats Revenue Estimates
Ovid Therapeutics (OVID) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to earnings of $0.12 per share a year ago. These


